Drug interactions
Encorafenib + Lidocaine-prilocaine
Severity: Minor
Encorafenib and Lidocaine-prilocaine: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Encorafenib has mixed inhibitory and inducing effects on CYP3A4, so lidocaine exposure could rise or fall unpredictably. After topical lidocaine-prilocaine at labeled doses, systemic exposure is low and clinical relevance is limited.
What this interaction means in plain words
Encorafenib and Lidocaine-prilocaine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Encorafenib belongs to Oncology; Lidocaine-prilocaine belongs to Genitourinary.
Why it happens
Encorafenib both inhibits and induces CYP3A4, altering lidocaine metabolism in an unpredictable direction.
What to do
No routine change is needed for standard topical use. Monitor for lidocaine toxicity or inadequate anesthesia if large areas or repeated applications are required.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Encorafenib and Lidocaine-prilocaine, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Lidocaine-prilocaine
- Lidocaine-prilocaine + Phenazopyridine Major
- Bupivacaine implant + Lidocaine-prilocaine Moderate
- Bupivacaine liposome + Lidocaine-prilocaine Moderate
- Disopyramide + Lidocaine-prilocaine Moderate
- Elvitegravir / cobicistat / emtricitabine / tenofovir df + Lidocaine-prilocaine Moderate
- Lidocaine-prilocaine + Mexiletine Moderate
Other interactions of Encorafenib
Frequently asked questions
Can I take Encorafenib with Lidocaine-prilocaine?
MediHelp rates the interaction as minor. Encorafenib and Lidocaine-prilocaine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Encorafenib has mixed inhibitory and inducing effects on CYP3A4, so lidocaine exposure could rise or fall unpredictably. After topical lidocaine-prilocaine at labeled doses, systemic exposure is low and clinical relevance is limited.
How serious is the interaction between Encorafenib and Lidocaine-prilocaine?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine change is needed for standard topical use. Monitor for lidocaine toxicity or inadequate anesthesia if large areas or repeated applications are required.
What other medicines interact with Lidocaine-prilocaine?
MediHelp also lists interactions of Lidocaine-prilocaine with, for example, Phenazopyridine, Bupivacaine implant, Bupivacaine liposome. The full list is on the Lidocaine-prilocaine page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
